Jones Amber D, Capriotti Zachary, Santos Erin, Lin Angel, Van Duyne Rachel, Smith Stephen, Klase Zachary
Department of Biological Sciences, University of the Sciences, Philadelphia, Pennsylvania, United States of America.
Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
PLoS One. 2025 Aug 28;20(8):e0328706. doi: 10.1371/journal.pone.0328706. eCollection 2025.
HIV-1 controllers are a rare population of individuals that exhibit spontaneous control of HIV-1 infection without antiretroviral therapy. Understanding the mechanisms by which HIV-1 controllers maintain and eventually lose this ability would be highly valuable in HIV-1 cure or vaccine research. Previous work revealed the ability of CD8+ T cells isolated from HIV-1 controllers to suppress HIV-1 replication in matched CD4+ T cells and PBMCs ex vivo and suggested the loss of control may be tied to CD8+ T cell exhaustion.
We explored whether CD8+ T cell exhaustion plays a role in the maintenance and loss of control by examining immune characteristics of HIV-1 persistent controllers and transient controllers who lost control within the duration of the study. Using flow cytometry, we analyzed exhaustion marker expression on CD8+ T cells from HIV-1 controllers and determined that they maintain a unique exhaustion profile as compared to people without HIV-1 and HIV-1 standard progressors. The low level of T cell exhaustion seen in HIV-1 controllers was reversed when these individuals lost control and showed increased viral loads. Combinatorial immune checkpoint blockade targeting exhaustion markers was able to restore ex vivo control in CD8+ T cells from former controllers.
These results suggest that CD8+ T cell exhaustion compromises the ability to control viral replication in HIV-1 controllers. The character of exhaustion in response to HIV-1 and therapy is distinct in HIV-1 persistent controllers, transient controllers and standard progressors.
HIV-1 控制者是一类罕见人群,他们在未经抗逆转录病毒治疗的情况下能自发控制 HIV-1 感染。了解 HIV-1 控制者维持并最终丧失这种能力的机制,对于 HIV-1 治愈或疫苗研究具有极高价值。此前的研究揭示,从 HIV-1 控制者体内分离出的 CD8+ T 细胞能够在体外抑制匹配的 CD4+ T 细胞和外周血单核细胞(PBMCs)中的 HIV-1 复制,并表明控制能力的丧失可能与 CD8+ T 细胞耗竭有关。
我们通过研究 HIV-1 持续控制者以及在研究期间失去控制的短暂控制者的免疫特征,探讨 CD8+ T 细胞耗竭在维持和丧失控制能力方面是否发挥作用。利用流式细胞术,我们分析了 HIV-1 控制者 CD8+ T 细胞上的耗竭标志物表达情况,并确定与未感染 HIV-1 的人和 HIV-1 标准进展者相比,他们维持着独特的耗竭特征。当这些个体失去控制且病毒载量增加时,HIV-1 控制者中所见的低水平 T 细胞耗竭情况发生了逆转。针对耗竭标志物的联合免疫检查点阻断能够恢复来自既往控制者的 CD8+ T 细胞的体外控制能力。
这些结果表明,CD8+ T 细胞耗竭损害了 HIV-1 控制者控制病毒复制的能力。在 HIV-1 持续控制者、短暂控制者和标准进展者中,对 HIV-1 和治疗产生的耗竭特征各不相同。